Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$10M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 12 most recent Form 4 transactions.
| Hemab Therapeutics… |
| CCONV◆ |
| 71,866 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV◆ | 23,343 | — | — | — | Open the original filing on SEC.gov |
| May 4 | COAG | Hemab Therapeutics… | CCONV | 4.2M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 12.6M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 5.6M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 25.9M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV◆ | 18M | — | — | — | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | PBUY | 555,555 | $18.00 | $10M | +16.7% | Open the original filing on SEC.gov |
| May 1 | AVLN | Avalyn Pharma Inc. | CCONV | 3.3M | — | — | — | Open the original filing on SEC.gov |